Epigenetic regulation of TIMP-3 expression in human macrophages via physiological and pharmacological modification of histone3 lysine27 (H3K27)
- 1 August 2025
- journal article
- research article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 52 (1) , 1-17
Abstract
Background Tissue inhibitor of metalloproteinases-3 (TIMP-3) prevents over-activity of metalloproteinases, thereby reducing the severity of several immune/ inflammatory diseases in which T-lymphocyte-stimulated macrophage invasion plays an essential role. However, the underlying mechanism of TIMP-3 expression and its modulation by anti-inflammatory agents are poorly understood. Methods and results Using RT-qPCR measurements in human macrophages, we showed that TIMP-3 steady-state and pre-spliced mRNAs are induced by the Thelper2 cytokine, interleukin-4 (IL-4) but downregulated by the pro-inflammatory Thelper1 cytokine, interferon-γ (IFN-γ), an inhibitory effect confirmed at the protein level. These effects of IL-4 and IFN-γ were independent of changes in the lineage determining transcription factors, CEBP-β, SP-1 and PU1/ETS, suggesting that epigenetic regulation might be important. We investigated the action of GSK-J4, an inhibitor of the histone3 lysine27 (H3K27) demethylase (KDM6) enzymes. GSK-J4 decreased basal and IL-4 induced TIMP-3 levels, concomitant with increased H3K27 tri-methylation (H3K27me3) by Chromatin Immunoprecipitation. Moreover, using adenovirus-mediated silencing, TIMP-3 expression was found to be specifically regulated by KDM6B. GSK-J4 had no effect on IFN-γ induced inhibition of TIMP-3 mRNA, which was instead accompanied by a fall in H3K27 acetylation at the TIMP-3 promoter. The histone deacetylase (HDAC) inhibitor, MS-275, completely reversed this fall and partially restored TIMP-3 expression. Conclusions In conclusion GSK-J4 reduces TIMP-3 expression and might therefore paradoxically increase macrophage invasion. By contrast, the HDAC inhibitor MS-275 antagonised the depression of TIMP-3 expression by IFN-γ, which should reduce macrophage invasion.Keywords
This publication has 49 references indexed in Scilit:
- JMJD3 downregulates IL4i1 aggravating lipopolysaccharide‐induced acute lung injury via H3K27 and H3K4 demethylationEnvironmental Toxicology, 2022
- Macrophage nuclear factor erythroid 2‐related factor 2 deficiency promotes innate immune activation by tissue inhibitor of metalloproteinase 3–mediated RhoA/ROCK pathway in the ischemic liverHepatology, 2021
- Targeting foam cell formation in inflammatory brain diseases by the histone modifier MS‐275Annals of Clinical and Translational Neurology, 2020
- Macrophage M1/M2 polarizationEuropean Journal of Pharmacology, 2020
- Green tea–induced epigenetic reactivation of tissue inhibitor of matrix metalloproteinase‐3 suppresses prostate cancer progression through histone‐modifying enzymesMolecular Carcinogenesis, 2019
- EZH2 regulates cancer cell migration through repressing TIMP-3 in non-small cell lung cancerMedical Oncology, 2013
- HDAC inhibitor MS‐275 attenuates the inflammatory reaction in rat experimental autoimmune prostatitisThe Prostate, 2011
- Distinct pharmacological properties of second generation HDAC inhibitors with the benzamide or hydroxamate head groupInternational Journal of Cancer, 2007
- TGF‐β‐induced expression of tissue inhibitor of metalloproteinases‐3 gene in chondrocytes is mediated by extracellular signal‐regulated kinase pathway and Sp1 transcription factorJournal of Cellular Physiology, 2004
- TIMPs as multifacial proteinsCritical Reviews in Oncology/Hematology, 2004